Welcome to our dedicated page for Amedisys news (Ticker: AMED), a resource for investors and traders seeking the latest updates and insights on Amedisys stock.
Amedisys Inc (NASDAQ: AMED) provides essential home healthcare, hospice, and high-acuity care services across the United States. This news hub offers investors and industry professionals direct access to verified corporate announcements and financial updates from the home healthcare leader.
Track material developments including quarterly earnings reports, regulatory filings, clinical program expansions, and strategic partnerships. Our curated collection features official press releases, SEC disclosures, and market-moving updates - all organized chronologically for efficient research.
Key content categories include financial performance updates, Medicare/Medicaid compliance changes, care center acquisitions, leadership appointments, and clinical quality initiatives. Bookmark this page for real-time access to operational milestones that shape AMED's position in the $300B home healthcare market.
For stakeholders monitoring the shift toward value-based care models, this resource simplifies tracking of Amedisys' evolving service offerings and regulatory compliance status. Visit regularly to stay informed about critical developments affecting one of America's largest home health providers.
Amedisys, Inc. (NASDAQ: AMED) will announce its first quarter results for the period ending March 31, 2023, on May 3, 2023, post-market closure. An investor call will follow on May 4, 2023, at 11:00 a.m. ET, where executives will discuss the results. Investors can join the call by dialing (888) 437-3179 or (862) 298-0702. A replay will be available until June 4, 2023. Amedisys, a leader in home health, hospice, and high-acuity care, focuses on delivering personalized healthcare services. The company operates over 522 care centers across 37 states and serves more than 465,000 patients annually, performing over 11.2 million visits each year.
FAQ
What is the current stock price of Amedisys (AMED)?
What is the market cap of Amedisys (AMED)?
